Pharma channel feed

Fore! Am­gen to be­come ti­tle spon­sor of Irish Open

Last year
Marketing

Sanofi and As­traZeneca to make 230,000 ad­di­tion­al RSV im­mu­niza­tions avail­able, White House says

Last year
FDA+
Manufacturing

'Won­der­ful Christ­mas gift': Fed's sur­prise rate-cut plan springs hope of 2024 biotech mar­ket re­bound

Last year
Financing
Deals

Did the FTC have a good rea­son to block the Sanofi-Maze deal?

Last year
Deals

White House keeps fo­cus on low­er­ing drug prices, turns Re­gen­eron's con­tract lan­guage in­to new stan­dard

Last year
FDA+
Law

Pfiz­er’s para­dox: Al­bert Bourla walks a fine line as he tries to turn around 2023's worst-per­form­ing big drug­mak­er

Last year

PwC pre­dicts ac­tive 2024 for phar­ma deals as M&A val­ue climbs

Last year

Sanofi’s Mourenx pro­duc­tion site leaked a po­ten­tial­ly can­cer­ous neu­ro­tox­in for the sec­ond time 

Last year
Manufacturing

As phar­mas dou­ble down on dig­i­tal and AI, tal­ent is a key con­sid­er­a­tion, con­sul­tant says

Last year
Marketing

Supreme Court to re­view lim­i­ta­tions on abor­tion pill

Last year
Law

Ex­cite­ment over sick­le cell now shifts to long slog of de­liv­er­ing treat­ments, in piv­otal year for blue­bird and gene ther­a­py

Last year
Cell/Gene Tx

Pfiz­er plans an­oth­er $500M in cost cuts, ex­pects $3.1B in rev­enue from Seagen in 2024

Last year

House pass­es sweep­ing health­care price trans­paren­cy re­forms, rein­ing in PBM prac­tices

Last year
FDA+

No­vo Nordisk calls IRA 'un­prece­dent­ed de­par­ture' from US Con­sti­tu­tion

Last year
Law

FDA es­tab­lish­es new ad­vi­so­ry com­mit­tee for ge­net­ic meta­bol­ic dis­ease treat­ments

Last year
FDA+

FDA rolls out new draft guid­ance on ad­vanced man­u­fac­tur­ing tech

Last year
FDA+
Manufacturing

Mar­ket­ingRx roundup: Ab­b­Vie, Sanofi and Re­gen­eron lead phar­ma ad spend; BMS launch­es new eq­ui­ty grants

Last year
Marketing

Icosavax buy­out caps As­traZeneca’s long search for a vac­cine plat­form

Last year
Deals

Af­ter ground­break­ing year for RSV ap­provals, GSK looks to mod­el pe­di­atric suc­cess for adult vac­cines

Last year
Marketing

Klick Health of­fers $1M prize pool for agency em­ploy­ees with in­no­v­a­tive AI so­lu­tions

Last year
Marketing

Mer­ck ex­tends ADC push by lend­ing a hand to C4 with small up­front for pro­tein de­grad­er work

Last year
Deals

Pfiz­er to com­plete Seagen ac­qui­si­tion Thurs­day, An­gela Hwang to de­part amid ex­ec­u­tive shuf­fle

Last year
Deals

Fer­ring Phar­ma­ceu­ti­cals lays off 134 em­ploy­ees be­tween NJ and MN lo­ca­tions

Last year
People

Bi­par­ti­san House bill seeks to boost pe­di­atric drug de­vel­op­ment via new FDA penal­ties for non­com­pli­ance

Last year
R&D
FDA+
First page Previous page 84858687888990 Next page Last page
A service from the Financial Times